AstraZeneca is spearheading the creation of a new life sciences park, in Wuxi, China, that aims to nurture innovation by bringing together local and international companies, government, and medical and academic institutions to help create a world-class healthcare innovation ecosystem.
The International Life Science Innovation Park will be built by the Wuxi municipal government and Wuxi High-tech District and supported by AstraZeneca as a founding partner.
Image: https://www.biospectrumasia.com
